Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title Utility of Early Versus Late Androgen Deprivation in Prostate Cancer Patients with Biochemical Relapse
IRB CASE1811
CC CC00032
Hospital Main Campus
Stage N/A
Phase N/A
Disease Prostate
Description
- To measure the utility of treatment versus observation in patients with rising PSA
Inclusion Criteria
- All patients with rising PSA after definitive treatment of their prostate cancer with no evidence of metastatic disease are eligible for this study.
- The patient population includes patients with biochemical failure who are being followed at Taussig Cancer Institute or at Glickman clinics.
- The patient will be informed that their choice of whether to participate or not will have no influence on their medical care.
